Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Choosing the right investment app can be daunting for beginners. We break down the best options to help you start investing confidently.
24,582 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
With the Social Security trust fund projected to run dry by 2032, a painful payroll increase could become a central p...
Investors have watched Comfort Systems soar in recent years. This guide evaluates whether should comfort systems stoc...
Cathie Wood goes bargain isn’t a hype moment. It’s a disciplined approach to re-evaluating disrupted growth names aft...
Anchorage Digital confirms it holds Strategy’s STRC perpetual preferred stock, marking a high-profile move by a regul...
When a high-quality dividend stock dives by more than a third, smart investors look beyond the fall. This guide break...
Mercadolibre hits $14.5 billion in annual sales, marking a major milestone for Latin America's e-commerce and fintech...
A hedge fund quietly doubled down with an $8 million bet as euronet stock tanked this past year. Here’s what that mov...
As 2026 budget cycles unfold, investors are rethinking how the weapons that built army legacy translate into today’s ...
Compass Point flags three financials fresh ratings: wall on UWMC, RKT, and SLRC as rates ease and lending activity is...
Investors are eyeing Vera Bradley's 2026 path as it rhythms through product launches, wholesale relationships, and di...
Oracle’s 2026 story blends a sharp stock pullback with strong earnings momentum. Learn what’s driving the 18% drop, w...